MARKET

CHGCF

CHGCF

Chugai Pharmaceu
OTCPK
43.80
NaN%
Closed 09:30 11/19 EST
OPEN
--
PREV CLOSE
43.80
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
45.00
52 WEEK LOW
37.80
MARKET CAP
72.06B
P/E (TTM)
22.36
1D
5D
1M
3M
1Y
5Y
1D
Chugai Advances Pediatric Hemophilia Study as NXT007 Trial Recruits
TipRanks · 6d ago
Chugai and Roche Advance Enicepatide Heart-Risk Study in Obesity Market
TipRanks · 11/05 16:32
Citi Reaffirms Their Buy Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 10/29 11:30
Chugai Pharmaceutical Co (CHGCF) Gets a Buy from Morgan Stanley
TipRanks · 10/28 10:27
Chugai Pharmaceutical Earnings Call Signals Robust Growth
TipRanks · 10/28 00:18
Chugai Pharmaceutical GAAP EPS of ¥228.07, revenue of ¥1,068B
Seeking Alpha · 10/27 15:42
Chugai Highlights FX Impact in Nine-Month 2026 IFRS Results
TipRanks · 10/27 08:22
Chugai Pharmaceutical Posts Strong Nine-Month Earnings and Confirms 2026 Guidance
TipRanks · 10/27 08:22
More
About CHGCF
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALECENSA, Kadcyla, GAZYVA, CellCept, Zelboraf, Xeloda, Tamiflu, Tarceva, Tecentriq, Herceptin, Perjeta, cancer gene panel testing and others. These products are primarily used to treat conditions such as cancer, kidney disease and kidney transplantation, bone and joint diseases (rheumatoid arthritis), neurological and muscular diseases (neuromyelitis optica spectrum disorders, spinal muscular atrophy, and Duchenne muscular dystrophy), blood disorders (hemophilia and paroxysmal nocturnal hemoglobinuria), and eye diseases (retinal disorders). It also engages in administrative operations, the provision of scientific information on pharmaceuticals, investment activities, and the provision of influenza information services.

Webull offers Chugai Pharmaceutical Co Ltd stock information, including OTCPK: CHGCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHGCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHGCF stock methods without spending real money on the virtual paper trading platform.